45 phenotypes from 7 alleles in 9 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Vcam1tm1Dmil/Vcam1tm1Dmil C.129S4-Vcam1tm1Dmil	abnormal chorioallantoic fusion	J:69597
	decreased cell chemotaxis	J:227109
	increased B cell number	J:69597
	increased leukocyte cell number	J:69597
	increased monocyte cell number	J:69597
	increased T cell number	J:69597
	prenatal lethality, incomplete penetrance	J:69597
Vcam1tm1Dmil/Vcam1tm1Dmil either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)	abnormal chorioallantoic fusion	J:69597
	increased monocyte cell number	J:69597
	prenatal lethality, incomplete penetrance	J:69597
Vcam1tm1Dmil/Vcam1tm1Dmil either: B6.129S4-Vcam1tm1Dmil or (involves: 129S4/SvJae)	abnormal chorioallantoic fusion	J:69597
	prenatal lethality, incomplete penetrance	J:69597
Vcam1tm1Dmil/Vcam1tm1Dmil involves: 129S4/SvJae	decreased cell chemotaxis	J:227109
Vcam1tm1Roml/Vcam1tm1Roml involves: 129S1/Sv * C57BL/6J	abnormal allantois morphology	J:28110
	abnormal cardiovascular system morphology	J:23137
	abnormal chorioallantoic fusion	J:28110
	abnormal epicardium morphology	J:28110
	abnormal extraembryonic tissue morphology	J:23137
	abnormal interventricular septum morphology	J:23137, J:28110
	abnormal myocardium layer morphology	J:23137
	absent epicardium	J:23137
	decreased embryo size	J:23137, J:28110
	dilated allantois	J:23137
	disorganized myocardium	J:23137, J:28110
	embryonic lethality during organogenesis, complete penetrance	J:23137, J:28110
	failure of chorioallantoic fusion	J:23137
	hydropic allantois	J:28110
	pericardial effusion	J:23137, J:28110
	thin ventricle myocardium compact layer	J:23137, J:28110
Vcam1tm2.1Roml/Vcam1tm2.1Roml involves: 129S1/Sv * C57BL/6	preweaning lethality, complete penetrance	J:43561
Vcam1tm2Dmil/Vcam1tm2Dmil B6.129S4-Vcam1tm2Dmil	decreased cell chemotaxis	J:227109
Vcam1tm2Flv/Vcam1tm2Flv Tg(Mx1-cre)1Cgn/0 involves: 129S1/Sv * C57BL/6 * CBA	abnormal blood cell morphology/development	J:123142
	decreased bone marrow cell number	J:123142
Vcam1tm2Flv/Vcam1tm3Flv Tg(Tek-cre)12Flv/0 involves: 129S1/Sv * C3H * C57BL/6	abnormal B cell physiology	J:68147
	abnormal blood cell morphology/development	J:107447, J:123142
	abnormal bone marrow cell morphology/development	J:107447, J:123142
	abnormal CD4-positive, alpha-beta T cell physiology	J:68147
	abnormal CD8-positive, alpha-beta T cell physiology	J:68147
	abnormal lymphocyte physiology	J:68147
	abnormal splenic cell ratio	J:107447
	decreased B cell number	J:68147
	decreased body weight	J:107447
	decreased bone marrow cell number	J:68147, J:107447
	decreased CD4-positive, alpha-beta T cell number	J:68147
	decreased CD8-positive, alpha-beta T cell number	J:68147
	decreased immature B cell number	J:68147
	increased immature B cell number	J:68147
	increased leukocyte cell number	J:68147, J:107447
	spleen hyperplasia	J:107447
Vcam1tm2Roml/Vcam1tm2Roml involves: 129S1/Sv * C57BL/6	postnatal lethality	J:43561
	normal reproductive system phenotype	J:43561
Vcam1tm2Roml/Vcam1tm2Roml Tg(Mx1-cre)1Cgn/? involves: 129S1/Sv * C57BL/6 * CBA	abnormal humoral immune response	J:68148
	decreased B cell number	J:68148
	decreased mature B cell number	J:68148
	decreased transitional stage B cell number	J:68148
	increased B cell number	J:68148
	increased immature B cell number	J:68148
	increased mature B cell number	J:68148
	increased transitional stage B cell number	J:68148